One-year outcomes of thoracic endovascular stent graft repair for acute type B aortic penetrating ulcer combined with antiplatelet drugs - Summary - MDSpire

One-year outcomes of thoracic endovascular stent graft repair for acute type B aortic penetrating ulcer combined with antiplatelet drugs

  • By

  • Zhan-kui Du

  • Ya-song Wang

  • Ting-hao Zhao

  • Hou-lin He

  • Zhi-qiang Zhang

  • Xiao-zeng Wang

  • May 26, 2026

  • 0 min

Share

Objective:

To investigate the 12-month clinical outcomes and 6-month morphological changes of acute penetrating aortic ulcers (PAUs) after thoracic endovascular aortic repair (TEVAR) combined with antiplatelet (AP) drugs.

Key Findings:
  • 2
Interpretation:

Remove this section.

Limitations:
  • Retrospective design may introduce bias.
  • Limited sample size in the AP group.
Conclusion:

Revise to state only the findings without unsupported claims about safety.

Original Source(s)

One-year outcomes of thoracic endovascular stent graft repair for acute type B aortic penetrating ulcer combined with antiplatelet drugs

  • by Zhan-kui Du, Ya-song Wang, Ting-hao Zhao, Hou-lin He, Zhi-qiang Zhang, Xiao-zeng Wang

  • May 26, 2026

Related Content

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min
Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis